CD1d-expressing Dendritic Cells but Not Thymic Epithelial Cells Can Mediate Negative Selection of NKT Cells by Chun, Taehoon et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
J. Exp. Med. 
 

 
 The Rockefeller University Press • 0022-1007/2003/04/907/12 $8.00
Volume 197, Number 7, April 7, 2003 907–918
http://www.jem.org/cgi/doi/10.1084/jem.20021366
 
907
 
CD1d-expressing Dendritic Cells but Not Thymic Epithelial 
Cells Can Mediate Negative Selection of NKT Cells
 
Taehoon Chun,
 
1, 2 
 
Michael J. Page,
 
3 
 
Laurent Gapin,
 
4 
 
Jennifer L. Matsuda,
 
4
 
 
Honglin Xu,
 
1, 2 
 
Hanh Nguyen,
 
1, 2 
 
Hyung-Sik Kang,
 
2 
 
Aleksandar K. Stanic,
 
5
 
 
Sebastian Joyce,
 
5 
 
Walter A. Koltun,
 
3
 
 Michael J. Chorney,
 
3
 
 Mitchell Kronenberg,
 
4 
 
and Chyung-Ru Wang
 
1, 2
 
1
 
Gwen Knapp Center for Lupus and Immunology Research, and 
 
2
 
Committee on Immunology and Department of 
Pathology, University of Chicago, Chicago, IL 60637
 
3
 
Department of Surgery, Pennsylvania State University College of Medicine, Hershey, PA 17033
 
4
 
La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
 
5
 
Department of Microbiology and Immunology, Vanderbilt University, School of Medicine, Nashville, TN 37232
 
Abstract
 
Natural killer T (NKT) cells are a unique immunoregulatory T cell population that is positively
selected by CD1d-expressing thymocytes. Previous studies have shown that NKT cells exhibit
autoreactivity, which raises the question of whether they are subject to negative selection.
Here, we report that the addition of agonist glycolipid 
 
 
 
-galactosylceramide (
 
 
 
-GalCer) to a
fetal thymic organ culture (FTOC) induces a dose-dependent disappearance of NKT cells,
suggesting that NKT cells are susceptible to negative selection. Overexpression of CD1d in
transgenic (Tg) mice results in reduced numbers of NKT cells, and the residual NKT cells in
CD1d-Tg mice exhibit both an altered V
 
 
 
 usage and a reduced sensitivity to antigen. Further-
more, bone marrow (BM) chimeras between Tg and WT mice reveal that CD1d-expressing
BM-derived dendritic cells, but not thymic epithelial cells, mediate the efficient negative selec-
tion of NKT cells. Thus, our data suggest that NKT cells developmentally undergo negative
selection when engaged by high-avidity antigen or abundant self-antigen.
Key words: NKT cells • CD1 • negative selection • avidity model • lipid antigen
 
Introduction
 
Natural killer T cells (NKT cells)
 
*
 
 are a unique T lympho-
cyte subset that coexpress NK receptors and TCRs (1, 2).
Two main subsets of NKT cells have been identified: those
positively selected by CD1d (the major subset), and those
that are CD1d-independent (less than 20% in thymus and
liver; references 3 and 4). The majority of CD1d-restricted
NKT cells express a V
 
 
 
14-J
 
 
 
18 (V
 
 
 
14
 
 
 
) TCR rearrange-
ment preferentially associated with either V
 
 
 
8, V
 
 
 
7, or
V
 
 
 
2 (5–8). These cells are either CD4
 
 
 
 or CD4
 
 
 
CD8
 
 
 
(DN) and respond to stimulation by a marine sponge-
derived glycolipid, 
 
 
 
-galactosylceramide (
 
 
 
-GalCer; refer-
ence 9). The most striking characteristic of CD1d-
restricted NKT cells is their ability to promptly produce
large amounts of cytokines, in particular IL-4 and IFN-
 
 
 
,
upon primary stimulation through the TCR complex (10).
The rapid release of cytokines implies that NKT cells may
play a critical role in modulating the upcoming immune
responses. In support of this notion, several recent studies
showed that NKT cells are involved in prevention of au-
toimmune disease (11–14) and protection against bacterial
or parasitic infections (15–17).
The lineage relationship between NKT cells and con-
ventional T cells is controversial. Several lines of evidence
suggest that CD1d-restricted NKT cells represent a unique
lineage of T cells. First, the positive selection of NKT cells
is mediated by CD4
 
 
 
CD8
 
 
 
 double-positive (DP) thy-
mocytes (18, 19), while thymic epithelial cells are responsi-
ble for positive selection of conventional T cells. Second,
NKT cell development is less dependent than conventional
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Abbreviations used in this paper:
 
 
 
 
 
-GalCer, 
 
 
 
-galactosylceramide;
 
 
 
-GalCer, 
 
 
 
-galactosylceramide; BM, bone marrow; DC, dendritic cell;
DP, double positive; FTOC, fetal thymic organ culture; NKT cell, natu-
ral killer T cell; RTOC, reaggregate thymic organ culture; TEC, thymic
epithelial cell; Tg, transgenic.T
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Negative Selection of NKT Cells
 
T cells on signaling intermediates in the Ras pathway (20),
but instead requires a functional tyrosine kinase, Fyn (21,
22). Third, several factors are exclusively required for the
development of NKT cells but not conventional T cells,
including preTCR
 
 
 
 (23), Ets-1 (24), and membrane lym-
photoxin (25, 26). However, recent data suggested that,
like conventional T cells, NKT cells might be derived from
a DP thymic subset. Once the rearrangement has occurred,
the DP cells that express the canonical V
 
 
 
14 gene are posi-
tively selected by CD1d molecules and develop into NKT
cells (27). Using an intrathymic transfer approach, Benlagha
et al. (28) and Pellicci et al. (29) further identified a
NK1.1
 
 
 
 thymic population as precursors of NK1.1
 
 
 
 NKT
cells. As NKT cells might diverge from conventional T
cells at the DP precursor stage, it is of interest to study
whether any rules that govern the selection of conventional
T cells can also apply to NKT cells and whether novel
mechanisms might be employed for the selection/develop-
ment of this unique subset of T cells.
For conventional T cells, a key factor in determining
whether a DP thymocyte undergoes positive or negative
selection is the avidity and affinity of the TCR–ligand in-
teraction (30–32). T cells with low-to-intermediate avidity
for self-peptide/MHC class I or class II are positively se-
lected and differentiate into mature CD8
 
 
 
 or CD4
 
 
 
 T cells
while other T cells with high avidity for self-peptide/
MHC molecules are eliminated by negative selection. The
negative selection is finely tuned to create a window of T
cell avidity that will be devoid of dangerous (high avidity)
autoreactive T cells, but will still allow survival of self-reac-
tive (low avidity) T cells. Consistent with this notion, sev-
eral studies have shown that modulating the avidity of thy-
mocytes for ligand expressing cells in the thymus by
altering TCR affinity, coreceptor expression, or ligand
density influences the outcome of negative selection (30,
33–35). Recently, it has been found that populations of T
lymphocytes, including CD4
 
 
 
CD25
 
 
 
 regulatory T cells
(36), intraepithelial lymphocytes that express CD8
 
  
 
 (37),
and some CD1d-independent NK1.1
 
 
 
 T cells (38–40) can
be positively selected by self-agonists that negatively select
conventional T cells. It has been proposed that CD1d-
restricted NKT cells also are selected by self-agonists (2),
leading to the question of whether NKT cells are indeed
subject to negative selection. If this is the case, how might
this process differ from the negative selection of conven-
tional T cells? Here we have addressed these questions in
vitro using an agonist for the NKT cell TCR, and in vivo
by transgene-mediated increases in CD1d expression. The
data obtained are consistent with an avidity-dependent
negative selection process that is performed by dendritic
cells (DCs).
 
Materials and Methods
 
Antibodies, CD1 Tetramers, and Glycolipids.
 
Antibodies used in
this study include: FITC-conjugated mAbs specific for hamster
IgG, I-A
 
b
 
 (M5114), CD4 (RM4–5), CD5 (53–7.3), CD11c
(HL3), CD24 (HSA; M1/69), Ly49A (A1), TCR
 
 
 
 (H57–597),
V
 
 
 
2 (B20.6), V
 
 
 
6 (RR4–7), V
 
 
 
7 (TR310), and V
 
 
 
8 (MR5–2);
PE-conjugated mAbs specific for CD3
 
 
 
 (145–2C11), CD8
 
 
 
(53–6.7), and NK1.1 (PK136); Cy-Chrome-conjugated mAbs
specific for TCR
 
 
 
 (H57–597), and CD4 (RM4–5; BD Bio-
sciences). The CD1d-specific mAbs 5C6 (hamster IgG) has been
described previously (41). The generation of CD1d/
 
 
 
-GalCer
tetramer has been described previously (42). PE- and APC-con-
jugated tetramers were used in these experiments. 
 
 
 
-GalCer and
 
 
 
-GalCer were kindly provided by Dr. Koezuka (Kirin Brewery,
Gunma, Japan).
 
Mice.
 
C57BL/6 and RAG-deficient mice were purchased
from The Jackson Laboratory. Generation of CD1d-deficient
mice has been described previously (43). CD1d-deficient mice
used in this study were backcrossed onto C57BL/6 back-
ground for 12 generations. All animal work was approved by
the Institutional Animal Care and Use Committee of the Uni-
versity of Chicago and the La Jolla Institute for Allergy and
Immunology.
 
Cell Preparations and FACS
 
®
 
 Analysis.
 
Single cell suspensions
from thymus and spleen were prepared by mechanical disrup-
tion in RPMI 1640 medium containing 10% FBS (HyClone), 2
mM 
 
l
 
-glutamine, 20 mM HEPES, 50 
 
 
 
M 2-mercaptoethanol,
nonessential amino acids, sodium pyruvate, penicillin, and
streptomycin (RPMI-10). The lymphocytes from perfused liver
were isolated according to the method described by Goossens et
al. (44). Red blood cells from single cell suspensions were re-
moved when necessary by hypotonic lysis before cell surface
staining. Thymic stromal cell suspensions were prepared by di-
gestion with 0.1% trypsin, 0.5 mM EDTA for 40 min at 37
 
 
 
C.
Digestion was stopped by addition of immunofluorescence (IF)
buffer (HBSS containing 2% FBS and 0.1% NaN
 
3
 
) buffer. After
mechanical disruption of the lobe, cells were harvested and
washed two times with IF buffer before cell surface staining ex-
periments. Unless noted otherwise, cell culture reagents were
purchased from Life Technologies. After staining with various
combination of mAbs, cells were analyzed by flow cytom-
etry using a FACSCaliber™ (Becton Dickinson) with CELL
Quest™ or FlowJo software. Cell sorting was performed using
a MoFlo cell sorter (Beckman Coulter) and were typically of
 
 
 
95% purity.
 
Generation of K
 
b
 
-mCD1d1 Transgenic (CD1d Tg) Mice.
 
The
full-length 
 
CD1d1
 
 gene fragment was amplified from a 
 
CD1d1
 
-
containing plasmid (provided by Dr. Luc Van Kaer, Vander-
bilt University) by PCR using the following primers: 5
 
 
 
-GGG-
GGACTAGTATGCGGTACCTACCATGGCTGTTGCTGT-
GGG-3
 
 
 
, forward; 5
 
 
 
-GGGGGATCGATTCATCACCGGAT-
GTCTTGATAAGCGCTTCTCC-3
 
 
 
, reverse. The chimeric
gene was generated by ligating the 2.9 kb SpeI-ClaI 
 
CD1d1
 
 frag-
ment with a 2 kb NotI/SpeI fragment containing the promoter of
the 
 
H-2K
 
b
 
 gene, and a 0.2 kb ClaI–XhoI fragment containing
bovine growth hormone poly-adenylation gene. The entire con-
struct was cloned into the NotI and XhoI sites of the pBluescript
KS (Stratagene). Microinjection of chimeric DNA fragment into
the pronuclei of fertilized oocytes of (BALB/c 
 
 
 
 B6) F1 mice
was performed by The Jackson Laboratory. Transgenic mice were
identified by PCR analysis using primers specific for the 
 
H-2K
 
b
 
promoter (5
 
 
 
-GCCGCGGACGCTGGATATAAAGTC-3
 
 
 
) and
the 
 
CD1d1
 
 gene (5
 
 
 
-CCTGGGACCATGGCTTCGTGAAGC-
3
 
 
 
). A line of CD1d Tg mice was established by backcrossing Tg
founder mice with B6 mice for five to six generations. All subse-
quent screening for transgenic mice was done by PCR as de-
scribed above. CD1d Tg mice and littermates were analyzed at
the age of 10–16 wk.T
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Fetal Thymic Organ Cultures and Reaggregated Thymic Organ Cul-
ture.
 
Thymus lobes were harvested on E15-E16 and placed on
Transwell filters (Costar) or nitrocellulose filters (Millipore). Thy-
muses were cultured in DMEM (Hyclone), supplemented with
20% FCS (Hyclone), glutamine, sodium pyruvate, nonessential
amino acids, 2-
 
 
 
 mercaptoethanol, and antibiotics, in the pres-
ence or absence of the indicated concentrations of glycolipids, at
37
 
 
 
C, 7% CO
 
2
 
 for 21 d unless otherwise indicated. Reaggregated
thymic organ culture (RTOC) experiments were performed as
described by Jenkinson et al. (45). Thymic stromal cells (TSCs)
from B6 were prepared by disaggregating fetal thymic lobes pre-
viously cultured for 5 d in 1.35 mM deoxyguanosine (Sigma-
Aldrich) using 0.05% trypsin and 0.02% EDTA. CD4
 
 
 
CD8
 
 
 
(DP) thymocytes from WT and CD1d Tg mice were obtained by
gently grinding freshly isolated newborn thymus lobes. The re-
sulting suspensions were sorted for DP thymocytes using FITC-
anti-CD4 and PE-anti-CD8. Reaggregates were formed by
mixing together the desired TSC and thymocytes at 1:1 cell ratio
(absolute number, 5 
 
 
 
 10
 
5
 
 of each cell type). After pelleting the
cells by centrifugation, the cell mixture was placed as a standing
drop on the upper membrane surface, and incubated for 5 d at
37
 
 
 
C in RPMI 1640–10.
 
Cytokine Assay.
 
Thymocytes, splenocytes, or hepatic lym-
phocytes (5 
 
 
 
 10
 
5
 
 cells/well) were stimulated either with 100
ng/ml of 
 
 
 
-GalCer or with anti-CD3 (2C11) coated 96-well
plate in a final volume of 200 
 
 
 
l of RPMI-10. After 48 h, the
culture supernatants were harvested, and the levels of IL-4 and
IFN-
 
 
 
 were quantitated by sandwich ELISA (BD Biosciences).
To compare the affinity of NKT cells, equal numbers of tet-
ramer-positive NKT cells (2 
 
 
 
 10
 
4
 
 cells/well) from both WT and
Tg
 
 
 
 splenocytes were stimulated with serial dilution of 
 
 
 
-Gal-
Cer. After 48 h, the culture supernatants were harvested, and the
levels of IL-4 and IFN-
 
 
 
 were quantitated by ELISA.
 
Adoptive Transfer.
 
Bone marrow (BM)-derived cells were de-
pleted of T cells by anti-Thy-1.2 (J1j.10; American Type Culture
Collection) coupled with rabbit complement (Hornby). Recipi-
ent mice received 980 rad (700 rad in the case of RAG KO mice)
4 h before injection with donor BM cells. A total of 10
 
7
 
 cells
were injected intravenously into recipient mice. In the case of
mixed BM chimeras, the appropriate BM cells and DCs were
mixed at the stated percentages and then injected. BM-derived
DCs (BM-DCs) were propagated from BM progenitor in culture
medium supplemented with 10 ng/ml of rmGM-CSF (R&D
Systems) and 1 ng/ml of rmIL-4 (R&D Systems). Culture me-
dium was renewed every other day. Maximal yield of DCs was
obtained between days 6 and 8 of culture. 10 wk after adoptive
transfer, splenocytes, and hepatic lymphocytes were collected and
the numbers of NKT cells were monitored by flow cytometry as
described above.
 
Statistical Analysis.
 
Mean values were compared using Stu-
dent’s 
 
t
 
 test for independent variables. Significant differences at
95% confidence are depicted with an asterisk 
 
*
 
 on each graph.
 
Results
 
Fetal Thymic Organ Culture with 
 
 -GalCer Suggests that
NKT Cells Are Susceptible to Negative Selection. Conven-
tional T cells undergo negative selection in the thymus to
eliminate T cells bearing high-affinity TCR to self-pep-
tide/MHC complexes. However, several NKT cell–
derived hybridomas recognize CD1d in the absence of ex-
ogenous antigens. This apparent autoreactivity of NKT cells
raises the question as to whether NKT cells also undergo
negative selection in the thymus. To investigate this, we
examined the effect of a potent NKT cell activator,  -Gal-
Cer, on NKT cell development in fetal thymic organ cul-
ture (FTOC). Fetal thymic lobes were harvested from ges-
tational day 15 B6 mice and incubated either with
 -GalCer, vehicle control (0.1% DMSO), or  -GalCer,
which differs from  -GalCer only by the anomeric con-
formation of the sugar moiety (46).  -GalCer is not anti-
genic but binds to CD1d. After 18 d of culture, thy-
mocytes were harvested and analyzed by flow cytometry.
Fig. 1 a showed that no CD1d/ -GalCer tetramer-posi-
tive (tetramer ) cells could be detected in the thymic lobes
cultivated in the presence of  -GalCer while  4–8% of
tetramer  cells were present in cultures with  -GalCer or
DMSO. This effect is specific for NKT cells, as  -GalCer
treatment had no effect on the number of CD4 CD8 ,
CD4 , and CD8  thymocytes (unpublished data). The ef-
fect of  -GalCer is dose-dependent (Fig. 1 b), with inter-
mediate levels of deletion obtained with a 10 7 M dose,
suggesting an avidity-dependent mechanism. Consistent
with the lower percentage of NKT cells, thymocytes iso-
lated from  -GalCer–treated lobes produced lower
amounts of IL-4 in response to stimulation with plate-
bound anti-CD3 (Fig. 1 c).
The activation of NKT cells by  -GalCer in vivo in-
duces the rapid secretion of IFN-  and IL-4 by hepatic
and splenic NKT cells followed by their disappearance
from these organs most likely due to activation-induced
cell death (AICD) (42, 47, 48). Hence, the addition of
 -GalCer into the FTOC could potentially induce AICD
of mature NKT cells generated in the culture without
having any effect on the selection of these cells. Although
unlike cells in the liver, thymic NKT cells are not subject
to AICD in vivo after  -GalCer injection (42, 49). To test
for this possibility,  -GalCer was added to FTOC at dif-
ferent time points after the initiation of in vitro culture.
After 20 d, thymic lobes were harvested and analyzed by
flow cytometry for the presence of tetramer  cells. As seen
in Fig. 1 d, tetramer  cells were readily detected in FTOC
that received  -GalCer antigen 13 d after the beginning of
culture. However, tetramer  cells were absent when
 -GalCer was added at earlier time points. Because
tetramer  cells are not detected before day 9 of the culture
(unpublished data), this result suggests that the addition of
 -GalCer early in the culture induces negative selection of
developing NKT cells, not AICD of mature NKT cells.
Taken together, these data suggest that developing CD1d-
reactive NKT cells can undergo negative selection in the
thymus.
Overexpression of CD1d Leads to Diminished Number of
NKT Cells in CD1d Transgenic Mice. While the experi-
ments described above demonstrate that NKT cells have
the capability to undergo negative selection in organ cul-
tures using a high affinity agonist, they do not demonstrate
that this can occur in vivo with the glycolipids naturally
presented by CD1d. Using TCR transgenic models, it has
been shown that the density of MHC class I and class II ex-T
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pressed at the cell surface affects the outcome of thymic se-
lection (50, 51). Limited diversity of the TCR repertoire of
NKT cells allows us to study the effect of CD1d surface
density on the NKT cell development in a non-TCR
transgenic system. Toward this end, we have generated a
CD1d transgenic mouse model, Kb-mCD1d1 Tg (CD1d
Tg), which directs CD1d expression under the control of a
classical MHC class I gene promoter. Fig. 2 shows that a
high level of CD1d expression can be detected from a vari-
ety of cell types in CD1d Tg mice. The level of CD1d
expression on Tg CD3low thymocytes and Tg CD3high
thymocytes was increased approximately threefold and
8–10-fold, respectively. Thymic stromal cells (MHC class
IIhigh) and thymic dendritic cells (DCs, CD11chi) express
20–40-fold higher levels of CD1d. Therefore, this animal
model allows us to investigate whether increased levels of
CD1d expression affect NKT cell development and which
cell type(s) mediate the effect.
Although CD1d/ -GalCer tetramers react with the
majority of invariant V 14  NKT cells, there are some
CD1d-restricted NKT cells that do not recognize  -Gal-
Cer (42, 52, 53). Therefore, we used both TCR- /
NK1.1 and CD1d/ -GalCer tetramer staining to examine
NKT cell development in the CD1d Tg mice. Compared
with the nontransgenic littermate controls, the number of
NK1.1  T cells decreased significantly in the CD1d Tg
mice. The reduction of the absolute number of NK1.1 
T cells in Tg mice was  50–65% in the thymus and liver,
but was less severe in the spleen and bone marrow ( 30–
40%). Notably, the number of NK1.1  T cells is greater
in Tg mice than that in CD1dKO mice, suggesting the
presence of residual CD1d-restricted NK1.1  T cells in
Tg mice (Fig. 3 a). The amount of cytokine production in
response to  -GalCer stimulation was also significantly
diminished in Tg mice as compared with WT mice (Fig.
3 b), consistent with the notion of impaired development
of CD1d-restricted NKT cells. Similar results were ob-
tained when lymphocytes from WT (WT), Tg, and
CD1dKO mice were stained with the CD1d/ -GalCer
tetramers (Fig. 3 c). Calculation of the absolute number of
NK1.1  T cells and tetramer  cells in Tg and control
mice indicated that the loss of tetramer  cells could ac-
count for almost all the decreased number of NK1.1  T
cells in Tg mice (Fig. 3 d). Thus, overexpression of CD1d
might have a lesser effect on the tetramer  CD1d-reactive
NKT cells.
Figure 1. CD1d-restricted NKT cell devel-
opment is decreased in  -GalCer-treated thy-
mic lobes. (a) Thymic lobes were harvested
from gestational day 15 B6 mice and incubated
with solvent (0.1% DMSO),  -GalCer (10 6
M), or  -GalCer (10 6 M). After 18 d of cul-
ture, thymocytes were harvested and stained
with FITC-anti-TCR  and PE-CD1d/ -Gal-
Cer tetramers. The plots are representative of
three experiments involving a total of 4 thymic
lobes for each condition, with the percentage of
tetramer  cells indicated. No significant differ-
ences in the total number of thymocytes were
observed between  -GalCer–treated lobes and
controls. In addition,  -GalCer treatment did
not affect the levels of CD1d surface expression.
(b) Thymic lobes were incubated with  -Gal-
Cer at indicated concentrations, and the num-
bers of tetramer  cells were analyzed by flow
cytometry. Representative data from one of two
experiments are shown. (c) Thymocytes from
each treated group (n   4) were pooled and
stimulated with plate-bound anti-CD3 (2C11,
10  g/ml) for 48 h. The amount of IL-4 secre-
tion was determined by sandwich ELISA. (d)
 -GalCer (10 6 M) was added to FTOC at
different time points after the beginning of the
culture. After 20 d, thymic lobes were harvested
and analyzed by flow cytometry for the pres-
ence of tetramer  cells. Representative data
from one of two experiments are shown.T
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We have not yet eliminated the possibility that overex-
pression of CD1d in Tg mice might result in peripheral de-
letion of high-affinity CD1d-restricted NKT cells. How-
ever, the diminished numbers of NKT cells are already
apparent in the thymus of Tg mice. To demonstrate that
thymic negative selection contributes to the observed
changes of NKT cells in CD1d Tg mice, we performed
FTOC from both Tg and WT mice. Compared with the
WT controls, total NKT cells generated in FTOC of Tg
thymic lobes were decreased about threefold (Fig. 4, a and
b), similar to the observed NKT cell reduction in the Tg
adult mice. The overexpression of CD1d has no noticeable
effect on the development of other thymocyte subsets in
FTOC (Fig. 4 a). Stimulation with anti-CD3 resulted in
lower amounts of IL-4 production from cells harvested
from Tg thymic lobes as compared with WT lobes (Fig. 4
c). Collectively, these data suggest that high levels of CD1d
expression leads to increased negative selection in Tg thy-
mus, which may be largely responsible for the drastic re-
duction of NKT cells in Tg mice.
Phenotypic and Functional Analysis of NKT Cells in CD1d
Transgenic Mice. It has been shown that the V  segments
used by CD1d-restricted V 14  NKT cells are skewed to-
ward V 8, V 7, and V 2 (5–8). To examine whether
high levels of CD1d expression alter the V  usage in
V 14  NKT cells from CD1d Tg mice, we stained spleno-
cytes from Tg and control mice with APC-conjugated
CD1d/ -GalCer tetramer and FITC-conjugated mAb spe-
cific for different TCR   segments. As shown in Fig. 5 a,
V  usage of tetramer  cells in Tg mice differs from WT
controls. Although V 8, V 7, and V 2 are still preferen-
tially used by tetramer  cells in Tg mice, the usage of V 8
and V 7 by the residual NKT cells in Tg mice is signifi-
cantly reduced while the usage of V 2 is increased. There
is no significant difference in the V  usage of conventional
T cells between Tg and controls.
To characterize the functional properties of the residual
NKT cells in Tg mice, we analyzed the cytokine secretion
capacity of NKT cells from Tg mice upon  -GalCer stim-
ulation. Equal numbers of tetramer  T cells from Tg or
WT mice were incubated with various concentrations of
 -GalCer for 48 h. As shown in Fig. 5 b, NKT cells from
both Tg and WT mice were able to produce comparable
amounts of IL4 and IFN-  in response to a high concentra-
tion of  -GalCer. However, NKT cells from Tg  mice se-
creted less amounts of cytokines than those of WT mice
when stimulated with lower concentrations of  -GalCer.
These results suggest that the residual NKT cells may es-
cape negative selection by means of modified TCR usage
and decreased affinity to CD1d and its ligand.
Thymic Stromal Cells Are Required for the Negative Selection
of NKT Cells Next, we performed RTOC between thy-
mic stromal cells of WT mice and DP thymocytes from ei-
ther wild type or Tg mice to determine whether Tg  stro-
mal cells are required for the negative selection of NKT
cells, and whether expression of CD1 transgene on DP
thymocytes influences the positive and/or negative selec-
tion of NKT cells. Purified DP thymocytes from Tg or
WT newborn mice were mixed with equal numbers of
stromal cells derived from deoxyguanosine-treated fetal
thymic lobes from WT mice. After 5 d in culture, the
number of NKT, CD4 , and CD8  cells were analyzed by
flow cytometric analysis. Fig. 6 shows that comparable
numbers of NKT cells were generated in the culture con-
taining either WT or Tg  DP thymocytes with WT thy-
mic stromal cells, suggesting that high levels of CD1d ex-
pression on thymic stromal cells are required for the
negative selection of NKT cells in the CD1d Tg model. In
addition, expression of CD1 transgene on DP thymocytes
did not enhance negative selection nor affect the positive
selection of NKT cells.
High Levels of CD1d Expression on Bone Marrow–derived
Cells Is Critical for the Negative Selection of NKT Cells.
Thymic stromal cells consist of thymic epithelial cells
(TECs), fibroblast-like cells, and some bone marrow–
derived cells (45). To investigate the contribution of CD1d
expression by hematopoietic cells or nonhematopoietic in
the selection of CD1d-restricted NKT cells, we established
bone marrow chimera between Tg and WT mice. The
Tg→WT bone marrow chimeras had significantly lower
numbers of NKT cells and significantly reduced capacity to
secrete IL-4 than did WT→WT chimeras (Fig. 7, a and b).
The amounts of IFN-  produced in Tg→WT bone mar-
Figure 2. CD1d expression in Kb-mCD1d1 transgenic (CD1d Tg)
mice. Flow cytometric analysis of cell surface expression of CD1d in WT
control and Tg mice. Cells were stained with FITC-anti-CD1d mAb
(5C6) and PE-conjugated anti-CD3, anti-CD11c, and anti-I-Ab. Specific
fluorescence profiles (thin line) obtained with anti-CD1d were overlayed
onto background profiles (dotted line) obtained with isotype control Ab
(hamster anti-TNP). Similar results were obtained with the other anti-
CD1d mAb, 3H3 (unpublished data). Results are representative of two
separate experiments.T
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row chimeras was also decreased (unpublished data). In
contrast, WT→Tg chimeras yielded NKT cell populations
similar in frequency to WT→WT chimeras, demonstrating
overexpression of CD1d on nonhematopoietic cells (i.e.,
TECs) cannot mediate negative selection of NKT cells. In
addition, CD1d-restricted NKT cells were undetectable in
chimeras that received hematopoietic cells from the
CD1dKO mice (KO→WT and KO→Tg), as reflected by
lack of IL-4 (Fig. 7 b) and IFN-  (data no shown) secretion
upon stimulation with  -GalCer. Our results indicate that
the level of CD1d expression on hematopoietic cells is crit-
ical in determining the outcome of NKT cell development.
Overexpression of CD1d on hematopoietic cells may cause
negative selection of CD1d-restricted NKT cells, while
lack of CD1d expression on hematopoietic cells precludes
the positive selection of NKT cells. This effect cannot be
compensated for by overexpression of CD1d on nonhe-
matopoietic cells. Thus, the level of CD1d expression on
various cell types is likely to be tightly regulated in vivo to
ensure the proper development and selection of NKT cells.
CD1d-expressing DCs Can Mediate the Negative Selection of
NKT Cells. Several bone marrow–derived cell types have
been shown to mediate the negative selection of conven-
tional T cells, including DCs (54), thymic B cells (55), and
thymocytes (56). Among these, DCs are the most potent
mediator of negative selection for conventional T cells (57).
To test whether overexpression of CD1d on DCs can in-
duce the negative selection of NKT cells, bone marrow
cells (107 cells) from WT mice were cotransferred with DCs
(3.3   106 CD11c  cells) from either WT or Tg mice to
Figure 3. The number of NKT cells and cytokine production capacity are reduced in CD1d Tg mice. (a) Lymphocytes isolated from thymus, spleen,
and liver of indicated mice were stained with FITC-anti-TCR  and PE-anti-NK1.1 and analyzed by flow cytometry. The absolute number of NKT
cells was calculated by percentage of NK1.1  T cells x total number of cells. Circles represent number of NKT cells from indicated tissues, and the hori-
zontal bar denotes the mean value. (b) Reduced cytokine production by NKT cells from Tg mice in response to  -GalCer. Lymphocytes from WT (n  
5) and Tg (n   5) were cultured in the presence of  -GalCer for 48 h. IL-4 and IFN-  levels in the supernatant were detected by ELISA. Lymphocytes
from CD1dKO mice did not produce detectable amounts of cytokines upon  -GalCer stimulation. (c) The number of CD1d/  GalCer tetramer  cells
is reduced in Tg mice. Lymphocytes from WT, Tg, and CD1dKO mice were stained with APC conjugated-CD1d/ -GalCer tetramers, FITC-anti-
CD4, and PE-anti-CD8 and analyzed by flow cytometry. Results are representative of three experiments. (d) Compared with WT mice, the absolute
number of CD1d/ -GalCer tetramer  cells in thymus, spleen and liver of Tg mice are significantly diminished. Data shown represent mean   SE of
seven mice in each group.T
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irradiated RAG-deficient mice. Flow cytometric analysis
confirmed that DCs isolated from Tg mice express much
higher levels of CD1d than DCs isolated from wild type
controls (Fig. 8 a). 10 wk after adoptive transfer, splenocytes
and hepatic lymphocytes from these chimeras were ana-
lyzed by flow cytometric analysis. Fig. 8 a shows that Tg 
DCs can be detected in the thymus of chimeras that re-
ceived the cotransfer of WT bone marrow and Tg  DCs,
indicating these DCs are accessible during thymic selection.
The number of NKT cells is significantly lower in the chi-
meras cotransferred with Tg  DCs compared with the chi-
meras cotransferred with WT DCs (Fig. 8 b). In agreement
with FACS® results, splenocytes and hepatic lymphocytes
from chimeras cotransferred with Tg  DCs secrete lower
amounts of IFN-  and IL-4 in response to  -GalCer stimu-
lation (Fig. 8 c). These results indicate that CD1d expressed
on DCs can mediate the negative selection of NKT cells.
Discussion
It has been suggested that NKT cells are biased toward
CD1d autoreactivity. Consistent with this, NKT cells have
Figure 4. Impaired NKT cell development in CD1d Tg fetal thymic
lobes. (a) Thymic lobes from both Tg (n   10) and littermate control
mice (n   5) were harvested on gestational day 16.5. After 10 d of cul-
ture, thymocytes were stained with either FITC-anti-HAS, CyChrome-
anti-TCR , and PE-anti-NK1.1; or FITC-anti-CD4 and PE-anti-
CD8 . The percentage of NKT cells in HSAlow gated population, and
the percentage CD4 , CD8 , and DP thymocytes are shown from a rep-
resentative experiment. (b) Decreased total number of NKT cells in Tg
thymic lobes. Circles represent pairs of thymic lobes, and the horizontal
bar denotes the mean value. (c) Thymocytes from Tg and control thymic
lobes were pooled and stimulated with anti-CD3 (2C11, 10  g/ml) for
48 h. The amount of IL-4 secretion was determined by sandwich ELISA.
Figure 5. Altered V  usage and affinity to  -GalCer of CD1d-
restricted NKT cells in CD1d Tg mice. (a) Splenocytes from indicated
mice were stained with APC conjugated-CD1d/ -GalCer tetramer, PE-
anti-TCR , and FITC-anti-V 2, V 6, V 7, and V 8. Percentage of
V  usage was calculated within gated TCR   cells (conventional T cells)
and CD1d/ -GalCer tetramer  cells (V 14  cells). Data shown represent
mean   SE of four mice in each group. (b) Reduced cytokine produc-
tion by CD1d/ -GalCer tetramer  cells from CD1d Tg mice in response
to  -GalCer. 2   104 tetramer  cells from CD1d Tg and WT mice were
cultured in the presence of various concentration of  -GalCer for 48 h.
IL-4 and IFN-  levels in the supernatant were detected by ELISA. Re-
sults are representative of two separate experiments.
Figure 6. Thymic stromal cells are required for the negative selection
of NKT cells. Reaggregate thymic organ cultures were made from equal
numbers of WT thymic epithelial cells and either DP thymocytes from
WT (top panel) or Tg mice (bottom panel). Cultures were harvested after
5 d and analyzed by flow cytometry for the development of NKT cells
and various thymocyte subsets. The percentage of NKT cells in HSAlow
gated population, and the percentage CD4 , CD8 , and DP thymocytes
are indicated from a representative experiment. Similar results were ob-
tained from two separate experiments.T
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914 Negative Selection of NKT Cells
an activated/effector or memory phenotype, even in germ
free animals (58). Also, some NKT cell hybridomas exhibit
CD1d autoreactivity (59), and freshly isolated NKT cells
respond to CD1d transfectants and DCs (60). In light of
this possible autoreactivity, it remained to be shown
whether NKT cell precursors that encounter a strong signal
during development undergo negative selection, and if so,
what cell type(s) can mediate the negative selection of
NKT cells. In this study, we showed that the addition of an
agonist glycolipid into FTOC or increasing CD1d surface
expression by transgenesis resulted in a drastic reduction of
NKT cells, supporting the notion that NKT cells are sus-
ceptible to negative selection. This is the first demonstra-
tion that a glycolipid can induce negative selection of a T
cell population. Although our models do not directly ad-
dress whether NKT cells can be negatively selected in
physiological conditions, our data provides a potential
mechanism for the negative selection for these highly au-
toreactive T cells. Similar to conventional T lymphocytes,
the negative selection of NKT cells is enhanced when
overall avidity is increased, and is mediated by CD1d ex-
pressing DCs, but not TECs. Many characteristics distin-
guish the differentiation of NKT cells from conventional T
cells in adult mice, including the cell type responsible for
their positive selection. The data presented here, however,
emphasize the similarity in the negative selection of the
two types of T cells, including the importance of bone
marrow–derived DCs in the negative selection process.
It has been shown previously that forced expression of a
CD8   transgene expressed under the control of the CD2
promoter prevented the development of CD1d-dependent
NKT cells (61). This result was interpreted as evidence for
negative selection of NKT cells, because CD8 interaction
Figure 7. CD1d expressed on bone marrow–derived cells are critical for
the negative selection of NKT cells. 107 bone marrow-derived cells from
WT, Tg, and CD1dKO mice were transferred into lethally irradiated re-
cipient mice (980 rad) by intravenous injection. After 10 wk, spleen and
liver lymphocytes from bone marrow chimera were isolated and analyzed
by flow cytometry. (a) Absolute NKT cell numbers of liver lymphocytes
and splenocytes from each group of bone marrow chimeras. (b) IL-4 pro-
duction by liver lymphocytes and splenocytes from each group of bone
marrow chimeras. 106 liver lymphocytes and splenocytes from indicated
group of mice were cultured in the presence of 100 ng/ml of  -GalCer
for 48 h. IL-4 levels in the supernatant were detected by ELISA.
Figure 8. DCs can mediate the negative selection of NKT cells. 107
bone marrow–derived cells from WT mice and 3.3   106 DCs (CD11c )
from either WT or CD1dTg mice were cotransferred to irradiated RAG-
deficient mice (700 rad) by intravenous injection. After 10 wk, spleen and
liver lymphocytes from chimera were isolated and analyzed by flow cy-
tometry. (a) Flow cytometry analysis of CD1d expression on bone mar-
row-derived DCs (CD11c , greater than 80% are CD11b CD8 ) from
donor mice and thymic DCs (CD11c ,  50–60% CD11b CD8 ,  30–
40% CD11b CD8 ) from reconstituted mice. The levels of CD1d ex-
pression on bone marrow–derived DCs from Tg animals is  10–20 fold
higher than those of WT controls. Specific fluorescence profiles (thin
line: WT DCs and thick line: Tg DCs) obtained with anti-CD1d (5C6)
were overlayed onto background profiles (dotted line) obtained with iso-
type control Ab. (b) Absolute NKT cell numbers of liver lymphocytes
and splenocytes from each group of chimeras. The absolute number of
NKT cells was calculated by percentage of NKT cells   total number of
cells. Data shown represent mean   SE of three mice in each group. (c)
Cytokine production by NKT cells of liver lymphocytes and splenocytes
from each group of chimeras was determined as described in Fig. 7.T
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with CD1d might lead to increased avidity of the canonical
V 14 TCR expressed by NKT cell precursors for CD1d.
Although this is an attractive hypothesis, other interpreta-
tions are possible, as the forced expression of CD8 has been
shown to partially inhibit the double negative to DP transi-
tion (62). NKT cells might be particularly affected by this,
as their precursor frequency is likely to be very low on ac-
count of the low frequency of the V 14-J 18 rearrange-
ment. Furthermore, results from preliminary experiments
indicate that the affinity of CD1d for CD8 is very low and
difficult to measure (unpublished data).
Our data suggest that the repertoire of NKT cells results
from a balance between positive and negative selection
mediated by endogenous ligands bound to CD1d mole-
cules. The overexpression of CD1d in the transgenic mice
may simply shift the balance such that an increased num-
ber of the V 14 NKT cells exceed the threshold for nega-
tive selection and are deleted. The restricted TCR reper-
toire of CD1d-reactive NKT cells allowed us to examine
the effect of CD1d density on the quantitative and qualita-
tive changes in the NKT cells population, which would
not be possible in a TCR Tg system. Despite their rela-
tively restricted TCR repertoire, the affinity of NKT cells
for   -GalCer plus CD1d complexes is heterogeneous.
This has recently been demonstrated in three V 14 NKT
cell hybridomas by equilibrium staining with  -GalCer/
CD1d tetramers (63). A similar heterogeneity might also
be true for the TCR avidity for complexes of CD1d with
endogenous glycolipids. Consistent with this, although
tetramer  NKT cells from CD1d Tg spleen displayed a
similar bias toward expression of the V 2, -7, and -8 seg-
ments, the relative reduction of NKT cells was more
prominent in the V 8-bearing NKT cells than the V 2-
bearing NKT cells (Fig. 5 a). This suggests that most of the
V 8-bearing NKT cells may have a higher affinity for the
CD1d/glycolipid complexes than the V 2-bearing NKT
cells. The heterogeneity of affinity makes it likely that the
residual NKT cells that can escape negative selection in
CD1d Tg mice have a reduced TCR affinity. Indeed,
these residual NKT cells have a reduced response to low
concentrations of  -GalCer in vitro. Nevertheless, the
limited TCR repertoire employed by V 14 NKT cells
poses constraints on the extent to which NKT cells are
able to escape the negative selection.
Studies using TCR   Tg mice have shown that several
alternative mechanisms could prevent conventional T cells
bearing autoreactive TCRs from being deleted, including
down-regulation of TCR and coreceptor as well as altered
expression of some surface molecules, such as CD5 (64–
66). As for NKT cells, engagement of Ly49 receptors with
ligand has been shown to negatively regulate autoreactivity
of NKT cells (60), indicating expression of NK receptors
on NKT cells may affect their selection. Our analysis of
the surface phenotype of CD1d-restricted NKT cells
showed that the number of CD4  tetramer  cells was re-
duced by 80–85%, while the number of CD4 CD8 
tetramer  cells was reduced by 25–40% in Tg mice (Fig. 3
c), suggesting that CD4  V 14  NKT cells might have
higher avidity to CD1d/glycolipid complexes and/or are
more sensitive to negative selection. However, our immu-
nofluorescence analysis showed that NKT cells in CD1d
Tg and WT mice expressed similar levels of TCR, CD4,
CD8, NK1.1, and Ly49A (unpublished data). This suggests
that modulating the expression levels of TCR and other
surface molecules is not the primary mechanism that allows
residual NKT cells to escape negative selection in CD1dTg
mice. Thus, it is likely that the residual NKT cells escape
negative selection in CD1dTg mice primarily by altering
the NKT cell repertoire.
Our bone marrow chimera study shows that overexpres-
sion of CD1d on hematopoietic cells, but not on nonhe-
matopoietic cells (i.e., TECs), was responsible for the re-
duction of NKT cells in CD1d Tg mice. Furthermore,
cotransfer of Tg DCs with WT bone marrow cells leads to
diminished NKT cell development, suggesting that similar
to conventional T cells, CD1d expressing on DCs can me-
diate the negative selection of NKT cells. It remains possi-
ble that other cell types of hematopoietic origin, such as
thymic B cells and macrophages, can also mediate the neg-
ative selection of NKT cells. In addition, although we de-
tected no effect of Tg DP thymocytes in the negative selec-
tion of NKT cells (Fig. 6), the level of CD1d expressed on
DP thymocytes in CD1d Tg mice is much lower than
other cell types. Thus, we cannot eliminate the potential
role of DP thymocytes in negative selection. We can con-
clude, however, that the inability of TEC to mediate nega-
tive selection was not due to insufficient levels of CD1d, as
expression of CD1d by DCs and TECs was similar in Tg
mice. Other factors then, such as accessory molecules, cell
type–specific ligands, and antigen processing and presenta-
tion pathways, must account for the ability of DCs to play a
role in the negative selection of NKT cells.
Recent studies showed that NKT cell development is
impaired in mice expressing a CD1d mutant which lacks an
endosomal targeting motif, and in mice deficient of cathep-
sin S, which disrupts the intracellular trafficking of CD1d
(67, 68). These results indicated that the selection and mat-
uration of NKT cells might require autologous CD1d-
bound ligands generated from the endosomal processing
pathway. Our finding that the addition of  -GalCer in-
duces the negative selection of NKT cells in B6 FTOC
raises some interesting questions about the potential role of
self-glycolipids in shaping the repertoire of mature CD1d-
restricted NKT cells. As the surface level of CD1d is un-
changed in  -GalCer–treated thymocytes and DCs (un-
published results), qualitative and quantitative differences in
TCR-CD1d recognition may be a critical determinant of
NKT cell fate. Thus, it is possible that during infection or
stress, the outcome of NKT cell selection might be affected
by either modulating the levels of CD1d expression and/or
varying the supply of glycolipids.
NKT cells are potent immunoregulatory cells that play a
significant role in regulating autoimmunity and immune
responses against microbes and tumors (69). As such, the
repertoire of NKT cells must be tightly regulated to main-
tain a pool of functional NKT cells while at the same timeT
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916 Negative Selection of NKT Cells
eliminating dangerous autoreactive NKT cells. Our study
suggests that negative selection plays a major role in elimi-
nating the high affinity self-reactive NKT cells, while other
factors might fine-tune the resulting NKT cell repertoire.
Further investigation will be required to understand how
these mechanisms are altered, or can be manipulated, in in-
fection and autoimmunity.
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